Who
James R. Tobin
Director
Company insider
Files Form 4 as: Director, Globus Medical; Director, TransMedics Group; Director, Lyra Therapeutics; Director, Oxford Immunotec Global; Director, Corindus Vascular Robotics; Director, Chiasma; Director, Curis; President & CEO, Boston Scientific.
In numbers
- Trades disclosed
- 218
- Buys
- 0
- Sells
- 20
- Bought
- $0
- Sold
- $25.2M
- Companies
- 9
- Companies where not an officer
- 8
- First trade
- 28 Feb 2006
- Last trade
- 15 Sep 2026
- Last filed
- 16 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Sep 2026filed 16 Sep 2026 | GMED Globus MedicalMedical Devices | SEC FORM 4 Code M | $806K15,000 at $53.75 | filing |
| 15 Sep 2026filed 16 Sep 2026 | GMED Globus MedicalMedical Devices | SEC FORM 4 Code M | $955K15,000 at $63.68 | filing |
| 15 Sep 2026filed 16 Sep 2026 | GMED Globus MedicalMedical Devices | SEC FORM 4 Sold | $2.2M30,000 at $74.58 | filing |
| 15 Sep 2026filed 16 Sep 2026 | GMED Globus Medicaloption or derivative · Medical Devices | SEC FORM 4 Code M | —15,000 at $0.00 | filing |
| 15 Sep 2026filed 16 Sep 2026 | GMED Globus Medicaloption or derivative · Medical Devices | SEC FORM 4 Code M | —15,000 at $0.00 | filing |
| 15 Sep 2026filed 16 Sep 2026 | GMED Globus Medicaloption or derivative · Medical Devices | SEC FORM 4 Code M | —15,000 at $0.00 | filing |
| 15 Sep 2026filed 16 Sep 2026 | GMED Globus Medicaloption or derivative · Medical Devices | SEC FORM 4 Code M | —15,000 at $0.00 | filing |
| 15 Sep 2026filed 16 Sep 2026 | GMED Globus MedicalMedical Devices | SEC FORM 4 Code M | $806K15,000 at $53.75 | filing |
| 15 Sep 2026filed 16 Sep 2026 | GMED Globus MedicalMedical Devices | SEC FORM 4 Code M | $955K15,000 at $63.68 | filing |
| 15 Sep 2026filed 16 Sep 2026 | GMED Globus MedicalMedical Devices | SEC FORM 4 Sold | $2.2M30,000 at $74.58 | filing |
| 17 Aug 2026filed 17 Aug 2026 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code G | —18,000 at $0.00 | filing |
| 17 Aug 2026filed 17 Aug 2026 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code G | —18,000 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code A | —2,922 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code A | —2,922 at $0.00 | filing |
| 21 Jan 2026filed 23 Jan 2026 | GMED Globus Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 21 Jan 2026filed 23 Jan 2026 | GMED Globus Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 22 May 2025filed 23 May 2025 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code A | —2,134 at $0.00 | filing |
| 14 May 2025filed 16 May 2025 | Lyra Therapeuticsoption or derivative | SEC FORM 4 Code A | —32,000 at $0.00 | filing |
| 23 Jan 2025filed 28 Mar 2025 | GMED Globus Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 13 Sep 2024filed 17 Sep 2024 | TMDX TransMedics GroupMedical Devices | SEC FORM 4 Code G | —18,000 at $0.00 | filing |
News
Comparing Lifeward (NASDAQ:LFWD) and Globus Medical (NYSE:GMED)GMED · themarketsdaily.com · 6 Oct 2026
0 headlines in the last 90 days name James R. Tobin; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.